Ralitoline

Ralitoline

SCHEMBL9813595

Cc1cccc(Cl)c1NC(=O)C=C1SCC(=O)N1C

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMD14 O00487 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ GAA P10253 1/20 0.41
▸ LCK P06239 9/20 0.40
▸ MAPK14 Q16539 7/20 0.40
▸ MAPK13 O15264 1/20 0.40
▸ EGFR P00533 1/20 0.40
▸ FYN P06241 1/20 0.40
▸ HCK P08631 1/20 0.40
▸ SRC P12931 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ MAPK12 P53778 1/20 0.40
▸ MAPK11 Q15759 1/20 0.40
▸ PDK1 Q15118 1/20 0.40
▸ PDK2 Q15119 1/20 0.40
▸ PDK3 Q15120 1/20 0.40
▸ PDK4 Q16654 1/20 0.40
▸ MAOB P27338 1/20 0.37
▸ CHRNA7 P36544 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ralitoline SCHEMBL635346 1.00 PSMD14 (0.55) PSMD14ALDH1A1TDP1GAALCK
SCHEMBL9813552 0.93 ALDH1A1 (0.59) PSMD14ALDH1A1TDP1GAAPDK1
SCHEMBL9813551 0.93 ALDH1A1 (0.59) PSMD14ALDH1A1TDP1GAAPDK1
SCHEMBL9813569 0.92 PSMD14 (0.61) PSMD14ALDH1A1TDP1GAA
SCHEMBL9813566 0.92 PSMD14 (0.61) PSMD14ALDH1A1TDP1GAA
SCHEMBL10853625 0.85 PSMD14 (0.60) PSMD14ALDH1A1TDP1GAA
SCHEMBL9813540 0.85 PSMD14 (0.60) PSMD14ALDH1A1TDP1GAA
SCHEMBL9813725 0.84 KMT2A (0.43) PSMD14ALDH1A1TDP1GAALCK
SCHEMBL10852036 0.84 KMT2A (0.43) PSMD14ALDH1A1TDP1GAALCK
SCHEMBL9813610 0.84 ALDH1A1 (0.71) PSMD14ALDH1A1TDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP claimed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US claimed
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP disclosed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US disclosed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP disclosed
Send feedback